Pipeline

Pipeline

Autifony’s pipeline includes clinical stage programmes for Schizophrenia, age related hearing loss, Fragile X and earlier stage programmes focused on ALS and Alzheimer’s Disease.

Autifony has been granted Orphan Drug Designation for AUT00206 for the treatment of Fragile X Syndrome.

CompoundIndicationLead OptimizationPreclinical DevelopmentPhase IPhase II
AUT00201Schizophrenia
AUT00206Age Related Hearing Loss
Back up compoundsFragile X, Pain
Novel ion channel modulatorALS
New chemistryBroad Indications

Related News

18Dec

Autifony Therapeutics and Boehringer Ingelheim collaborate on a novel therapeutic approach to a range of CNS disorders

0 Comments
Collaboration with funding of development activities gives Boehringer Ingelheim exclusive option to purchase certain Autifony assets to treat serious CNS... Read More →
10Jul

Autifony Therapeutics receives Orphan Drug Designation for AUT00206 for Fragile X Syndrome

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
18May

Autifony Therapeutics initiates recruitment into schizophrenia clinical trial for first-in-class drug

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
10Jan

Autifony Therapeutics announces positive results from Phase I study of AUT00206, a first-in-class Kv3 modulator for treatment of schizophrenia

0 Comments
Autifony Therapeutics Limited (“Autifony”), which is pioneering the development of novel pharmaceutical treatments for serious disorders of the central nervous... Read More →
09Aug

Autifony Announces Results from Completed CLARITY-1, Phase IIa Trial of AUT00063 in Age-related Hearing Loss

0 Comments
Autifony Therapeutics Limited, which is pioneering the development of novel pharmaceutical treatments for hearing disorders and other serious disorders of... Read More →
Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image